MiniMed director granted 13,889 RSUs

EISENBERG GLENN A reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 03/11/2026 - 04:31 PM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

EISENBERG GLENN A reported acquisition or exercise transactions in this Form 4 filing.

MiniMed Group, Inc. director Glenn A. Eisenberg received an equity grant of 13,889 shares of common stock in the form of restricted stock units. The units were awarded at no cash cost and vest on the one-year anniversary of the grant date. Following this award, he directly holds 13,889 shares and units, including shares to be issued upon future vesting of restricted stock units.

Insider Trade Summary

Grant/Award: 13,889 shares

Grant/Award 1 txn

Insider EISENBERG GLENN A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13,889	$0.00	$0.00

Holdings After Transaction: Common Stock — 13,889 shares (Direct)

Holdings Before and After: Common Stock, 0 to 13,889 shares (Direct)

Footnotes (2)

F1. Represents restricted stock units that vest on the one-year anniversary of the grant date.
F2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MiniMed Group (MMED) disclose in this Form 4?

MiniMed Group disclosed that director Glenn A. Eisenberg received an equity grant of 13,889 shares of common stock via restricted stock units. This is a compensation-related stock award, not an open-market purchase or sale, and reflects additional ownership tied to future vesting.

How many MiniMed Group (MMED) shares did Glenn A. Eisenberg acquire?

Glenn A. Eisenberg acquired 13,889 shares of MiniMed Group common stock in the form of restricted stock units. These units represent a right to receive shares over time, rather than an immediate cash purchase in the market, and increase his equity-based compensation.

What type of equity award did MiniMed Group (MMED) grant to its director?

The company granted Glenn A. Eisenberg restricted stock units, representing 13,889 shares of common stock. Restricted stock units are share-based awards that typically vest over time, aligning director compensation with the company’s longer-term performance and share price development.

When do Glenn A. Eisenberg’s MiniMed Group (MMED) restricted stock units vest?

The restricted stock units vest on the one-year anniversary of the grant date. Until vesting, the units represent a contractual right to receive MiniMed Group common shares in the future, rather than currently issued, freely tradable stock.

How many MiniMed Group (MMED) shares does Glenn A. Eisenberg hold after this grant?

After the grant, Glenn A. Eisenberg directly holds 13,889 shares and units of MiniMed Group common stock. This total includes shares that will be issued when one or more restricted stock unit awards vest in the future, as specified in the filing footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

EISENBERG GLENN A

(Last)

(First)

(Middle)

C/O 18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE

91325

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/09/2026		A		13,889⁽¹⁾	A	$0	13,889⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents restricted stock units that vest on the one-year anniversary of the grant date.

2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.

Remarks:

	/s/ Bryan F. Kelly, attorney-in-fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR